Several other equities analysts have also recently issued reports on XRAY. ValuEngine raised DENTSPLY SIRONA from a hold rating to a buy rating in a report on Saturday, May 4th. Barrington Research raised DENTSPLY SIRONA from a market perform rating to an outperform rating and set a $63.00 price objective for the company in a report on Monday, May 6th. HC Wainwright reissued a neutral rating and issued a $55.00 price objective (up previously from $49.00) on shares of DENTSPLY SIRONA in a report on Monday, May 6th. Zacks Investment Research cut DENTSPLY SIRONA from a buy rating to a hold rating in a report on Monday, May 6th. Finally, William Blair raised DENTSPLY SIRONA from a market perform rating to an outperform rating and set a $56.71 price objective for the company in a report on Monday, March 18th. Eight analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. The stock currently has an average rating of Buy and a consensus target price of $53.55.
Shares of XRAY opened at $53.75 on Friday. DENTSPLY SIRONA has a one year low of $33.93 and a one year high of $55.88. The company has a quick ratio of 1.35, a current ratio of 2.06 and a debt-to-equity ratio of 0.33. The stock has a market cap of $12.58 billion, a price-to-earnings ratio of 26.74, a PEG ratio of 2.05 and a beta of 1.11.
DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Friday, May 3rd. The medical instruments supplier reported $0.49 EPS for the quarter, topping the Zacks’ consensus estimate of $0.39 by $0.10. DENTSPLY SIRONA had a positive return on equity of 8.99% and a negative net margin of 26.48%. The company had revenue of $946.20 million during the quarter, compared to analysts’ expectations of $925.13 million. During the same quarter in the previous year, the firm posted $0.45 EPS. The firm’s revenue was down 1.0% compared to the same quarter last year. As a group, equities research analysts expect that DENTSPLY SIRONA will post 2.34 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, July 12th. Investors of record on Friday, June 28th will be paid a $0.0875 dividend. This represents a $0.35 annualized dividend and a dividend yield of 0.65%. The ex-dividend date of this dividend is Thursday, June 27th. This is a positive change from DENTSPLY SIRONA’s previous quarterly dividend of $0.09. DENTSPLY SIRONA’s payout ratio is currently 17.41%.
In related news, insider William E. Newell sold 3,000 shares of DENTSPLY SIRONA stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $54.73, for a total value of $164,190.00. Following the completion of the transaction, the insider now owns 28,212 shares in the company, valued at approximately $1,544,042.76. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Eric Brandt sold 9,160 shares of DENTSPLY SIRONA stock in a transaction dated Friday, May 3rd. The shares were sold at an average price of $53.45, for a total value of $489,602.00. Following the completion of the transaction, the director now owns 26,003 shares of the company’s stock, valued at approximately $1,389,860.35. The disclosure for this sale can be found here. In the last 90 days, insiders sold 123,922 shares of company stock valued at $6,790,905. 0.62% of the stock is owned by company insiders.
Institutional investors have recently made changes to their positions in the stock. Hanseatic Management Services Inc. purchased a new position in shares of DENTSPLY SIRONA in the 1st quarter valued at about $30,000. Harel Insurance Investments & Financial Services Ltd. purchased a new stake in DENTSPLY SIRONA during the 4th quarter worth approximately $26,000. Private Capital Group LLC increased its stake in DENTSPLY SIRONA by 105.3% during the 4th quarter. Private Capital Group LLC now owns 700 shares of the medical instruments supplier’s stock worth $26,000 after buying an additional 359 shares in the last quarter. Pinnacle Bank purchased a new stake in DENTSPLY SIRONA during the 4th quarter worth approximately $26,000. Finally, Truehand Inc purchased a new stake in DENTSPLY SIRONA during the 4th quarter worth approximately $27,000. Hedge funds and other institutional investors own 93.48% of the company’s stock.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
See Also: What is the Beige Book?
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.